Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-026728

Options or other derivatives

  • Director acquired 752,185 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Katkin Keith Director 2023-05-01 Grant or award · Stock Option (right to buy) +752,185 752,185 D
Loading xslF345X04/doc4.xml…